SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-002784
Filing Date
2017-05-08
Accepted
2017-05-08 15:02:04
Documents
45
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050817p.htm 10-Q 560198
2 EXHIBIT 31.1 exh_311.htm EX-31.1 9455
3 EXHIBIT 31.2 exh_312.htm EX-31.2 9440
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3592
5 EXHIBIT 32.2 exh_322.htm EX-32.2 3450
  Complete submission text file 0001171843-17-002784.txt   3927525

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bcrx-20170331.xml EX-101.INS 714156
7 XBRL SCHEMA FILE bcrx-20170331.xsd EX-101.SCH 48439
8 XBRL CALCULATION FILE bcrx-20170331_cal.xml EX-101.CAL 37469
9 XBRL DEFINITION FILE bcrx-20170331_def.xml EX-101.DEF 345216
10 XBRL LABEL FILE bcrx-20170331_lab.xml EX-101.LAB 321417
11 XBRL PRESENTATION FILE bcrx-20170331_pre.xml EX-101.PRE 349475
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 17821891
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1